Back to Markets
KRKorro Bio Inc

Korro Bio Inc

KRRO
Health CareBiotechnology: Pharmaceutical Preparations

$13.41

+0.0100 (+0.07%)

As of 05/29/26 EDT · USD

Compare
Low: $5.20Current: $13.41High: $55.89

Key Statistics

Open

$13.48

Day High

$13.52

Day Low

$12.59

Prev. Close

$13.40

VolumeShares traded today.

115.07K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$193.41M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.15

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$55.89

52W LowLowest price over the past 52 weeks.

$5.20

50D MAAverage closing price over the last 50 trading days.

$12.35

200D MAAverage closing price over the last 200 trading days.

$18.37

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+19.7%

1M

+6.3%

6M

+134.0%

YTD

+66.6%

1Y

+24.2%

About

David L. Lucchino is the Chief Executive Officer of Brenig Therapeutics, a Somerville, MA-based biotech company developing therapeutics for neurodegenerative diseases. He was previously the CEO of Frequency Therapeutics.

Company Facts

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade KRRO

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.